ICIs are presumed to be insufficiently effective in cases where infiltration of CD8+ T-cells in tumors is lacking, and an analysis of human melanomas has revealed that activation of the Wnt/β-catenin signaling pathway is associated with reduced TILs in tumors. The gene discussed is CD8A; the disease is melanoma.